05/13/2024
🔬 Unlocking Insights with GT Molecular’s Cancer Research Panels for the Bio-Rad QX200™/QX600™ ddPCR™ Platforms
GT Molecular has developed high-sensitivity PCR panels designed specifically for cancer research, providing valuable results for actionable mutations.
🌟 GT Molecular’s Patent-Pending Digital PCR Kits 🌟
â—ľ EGFR Panel targets over 30 actionable mutations in the EGFR gene!
â—ľ KRAS G12C;G12 Kit for the detection of KRAS G12C associated with non-small cell lung cancers (NSCLC).
â—ľ NPM1-W288FS*12 Insertion Kit (Beta) for the detection of NPM1-W288fs*12 mutations found in Acute Myeloid Leukemia.
🔍 Why Choose GT Molecular?
â—ľ High sensitivity (at least 0.01% VAF; 3-4 copies per reaction for all targets).
â—ľ Wet lab tested and validated with all necessary controls
â—ľ Economical and rapid results, even on the same day
â—ľ Compatible with FFPE and liquid biopsy sample types
đź“© Interested? We have many more assay on a variatey of platforms. Visit our website: http://gtmolecular.com or contact us directly for inquiries.
🚀🧬
Bio-Rad Laboratories Bio-Rad Genomics
American Association for Cancer Research (AACR)